Thyrocare Technologies Limited — Updates, 23-07-2025: Press Release

Thyrocare Technologies announced strong financial results for the quarter. Revenue from operations grew 23% YoY to INR 193.03 Cr. Normalized EBITDA surged 42% YoY to INR 63.35 Cr, and Profit After Tax jumped 62% YoY to INR 38.06 Cr. This robust performance was driven by 25% growth in Pathology and 6% in Radiology, with total test volumes increasing 15% to 46.9 million. The company also expanded its network by opening new labs in Bhagalpur, Kashmir, and Roorkee.